Baim Institute for Clinical Research is a leading, not-for-profit ARO that delivers insight, innovation and leadership in today's dynamic research environment
Reminder! Please join us in 30 minutes at 9:30 am EST for Baim Grand Rounds with Dr. Shamir Mehta, presenting "From COMPLETE to COMPLETE-2: Resolving the Anatomy vs. Physiology Debate in STEMI Multivessel Disease Revascularization." Zoom link: https://t.co/F7ykWpwiS5
#BaimInstitute
💙 World Diabetes Day | November 14
Today, we raise awareness, support those impacted by diabetes, and recognize the vital role of education and clinical research in advancing prevention, treatment, and better outcomes.
#BaimInstitute#WorldDiabetesDay#DiabetesAwareness
Reminder! Please join us for Baim Grand Rounds with Dr. Shamir Mehta on Monday, November 16, 2026, at 9:30 am EST, presenting "From COMPLETE to COMPLETE-2: Resolving the Anatomy vs. Physiology Debate in STEMI Multivessel Disease Revascularization." Zoom link: https://t.co/F7ykWpwiS5
#BaimInstitute
Join us for Baim Grand Rounds on Monday, November 30, 2026, at 9:30 am EST with @YumiKangEndo, presenting "The Many Faces of Obesity: Diverse Phenotypes, Expanding Therapeutic Horizons."
Zoom link: https://t.co/739NXTU1sL
#BaimInstitute
Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND.
https://t.co/T9kETx7V8D
Contributions from Baim faculty, @gabrielsteg and Harvey White.
#BaimInstitute#ClinicalResearch#Cardiology
Correction: Translating Guidelines into Practice: Implementation of NT-proBNP Testing for Early Heart Failure Detection in Diabetes, a Narrative Review.
https://t.co/wXzITlobH7
Contributions from Baim CSO, James Januzzi. #BaimInstitute#ClinicalResearch#Cardiology
Fatty acid synthase in cardiovascular disease: from molecular mechanisms to therapeutic targeting.
https://t.co/oDk7VwAASP
Contributions from Baim CSO, Dr. James Januzzi.
#BaimInstitute#ClinicalResearch#Cardiology
Extended Analyses of Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a).
https://t.co/YxmgOpRICJ
Contributions from Baim faculty, Stephen Nicholls and @LincoffMichael.
#BaimInstitute#ClinicalResearch#Cardiology
Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the FLOW Trial.
https://t.co/2cZA59wRZQ
Contributions from Baim faculty, @TheMahaf and @KatherineTuttl8#BaimInstitute#ClinicalResearch